Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Human Cowpox Infection Treatment & Management

  • Author: Nikki A Levin, MD, PhD; Chief Editor: Dirk M Elston, MD  more...
 
Updated: Sep 08, 2015
 

Medical Care

Because cowpox is generally a self-limited disease, treatment is largely supportive. Patients often do not feel well and require bed rest or, occasionally, hospitalization.

Antiviral medications are not routinely used in cases of human cowpox, nor are antibiotics given unless the patient has developed a secondary bacterial infection. However, studies in mice suggest a role for the viral DNA polymerase inhibitor cidofovir, given parenterally, topically, or in an aerosolized form, for disseminated cases of cowpox.[20, 21]

Patients should be made aware that their lesions are potentially infectious, but no person-to-person transmission has been reported. Occlusive bandages may be applied to avoid this risk.

In severe cases, antivaccinia gammaglobulin may be given.

Next

Surgical Care

Standard wound dressings may be applied to lesions. Draining of pus or removal of eschars may actually prolong infection or spread it to other body sites and is therefore not recommended.

Previous
Next

Consultations

Consult infectious disease and/or dermatology specialists for help in making a diagnosis and in differentiating it from parapoxvirus infections and other entities.

Previous
 
 
Contributor Information and Disclosures
Author

Nikki A Levin, MD, PhD Associate Professor of Medicine, Division of Dermatology, University of Massachusetts Medical School

Nikki A Levin, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Phi Beta Kappa, Sigma Xi

Disclosure: Nothing to disclose.

Specialty Editor Board

Richard P Vinson, MD Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Texas Medical Association, Association of Military Dermatologists, Texas Dermatological Society

Disclosure: Nothing to disclose.

Jeffrey Meffert, MD Associate Clinical Professor of Dermatology, University of Texas School of Medicine at San Antonio

Jeffrey Meffert, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, Association of Military Dermatologists, Texas Dermatological Society

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

References
  1. Esposito, JJ, Fenner F. Poxviruses. Knipe D, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, eds. Fields Virology. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001. Chapter 85.

  2. Burton JL. Of mice and milkmaids, cats and cowpox. Lancet. 1994 Jan 8. 343(8889):67. [Medline].

  3. Baxby D, Bennett M, Getty B. Human cowpox 1969-93: a review based on 54 cases. Br J Dermatol. 1994 Nov. 131(5):598-607. [Medline].

  4. Pelkonen PM, Tarvainen K, Hynninen A, et al. Cowpox with severe generalized eruption, Finland. Emerg Infect Dis. 2003 Nov. 9(11):1458-61. [Medline].

  5. Honlinger B, Huemer HP, Romani N, Czerny CP, Eisendle K, Hopfl R. Generalized cowpox infection probably transmitted from a rat. Br J Dermatol. 2005 Aug. 153(2):451-3. [Medline].

  6. Moss B, Shisler JL. Immunology 101 at poxvirus U: immune evasion genes. Semin Immunol. 2001 Feb. 13(1):59-66. [Medline].

  7. Dasgupta A, Hammarlund E, Slifka MK, Fruh K. Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules. J Immunol. 2007 Feb 1. 178(3):1654-61. [Medline].

  8. Byun M, Wang X, Pak M, Hansen TH, Yokoyama WM. Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface. Cell Host Microbe. 2007 Nov 15. 2(5):306-15. [Medline].

  9. Amer M, El-Gharib I, Rashed A, Farag F, Emara M. Human cowpox infection in Sharkia Governorate, Egypt. Int J Dermatol. 2001 Jan. 40(1):14-7. [Medline].

  10. Stolz W, Gotz A, Thomas P, et al. Characteristic but unfamiliar--the cowpox infection, transmitted by a domestic cat. Dermatology. 1996. 193(2):140-3. [Medline].

  11. Postma BH, Diepersloot RJ, Niessen GJ, Droog RP. Cowpox-virus-like infection associated with rat bite. Lancet. 1991 Mar 23. 337(8743):733-4. [Medline].

  12. Vestey JP, Yirrell DL, Aldridge RD. Cowpox/catpox infection. Br J Dermatol. 1991 Jan. 124(1):74-8. [Medline].

  13. Vestey JP, Yirrell DL, Norval M. What is human catpox/cowpox infection?. Int J Dermatol. 1991 Oct. 30(10):696-8. [Medline].

  14. Wolfs TF, Wagenaar JA, Niesters HG, Osterhaus AD. Rat-to-human transmission of Cowpox infection. Emerg Infect Dis. 2002 Dec. 8(12):1495-6. [Medline].

  15. Kurth A, Wibbelt G, Gerber HP, Petschaelis A, Pauli G, Nitsche A. Rat-to-elephant-to-human transmission of cowpox virus. Emerg Infect Dis. 2008 Apr. 14(4):670-1. [Medline].

  16. Lewis-Jones MS, Baxby D, Cefai C, Hart CA. Cowpox can mimic anthrax. Br J Dermatol. 1993 Nov. 129(5):625-7. [Medline].

  17. Rajan N, Carmichael AJ, McCarron BM. Human cowpox: presentation and investigation in an era of bioterrorism. J Infect. 2005 Oct. 51(3):e167-9. [Medline].

  18. Pahlitzsch R, Hammarin AL, Widell A. A case of facial cellulitis and necrotizing lymphadenitis due to cowpox virus infection. Clin Infect Dis. 2006 Sep 15. 43(6):737-42. [Medline].

  19. Schupp P, Pfeffer M, Meyer H, Burck G, Kolmel K, Neumann C. Cowpox virus in a 12-year-old boy: rapid identification by an orthopoxvirus-specific polymerase chain reaction. Br J Dermatol. 2001 Jul. 145(1):146-50. [Medline].

  20. Smee DF, Bailey KW, Sidwell RW. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice. Chemotherapy. 2003 Jun. 49(3):126-31. [Medline].

  21. Quenelle DC, Collins DJ, Kern ER. Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir. Antiviral Res. 2004 Jul. 63(1):33-40. [Medline].

  22. Kesson AM, Ferguson JK, Rawlinson WD, Cunningham AL. Progressive vaccinia treated with ribavirin and vaccinia immune globulin. Clin Infect Dis. 1997 Oct. 25(4):911-4. [Medline].

  23. Thornburg NJ, Ray CA, Collier ML, Liao HX, Pickup DJ, Johnston RE. Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challenge. Virology. 2007 Jun 5. 362(2):441-52. [Medline].

  24. Lee WC, Manjaly G, Skinner DW, O'Neill PM. Cowpox infection of the nose. J Laryngol Otol. 1996 Aug. 110(8):782-4. [Medline].

  25. Haase O, Moser A, Rose C, Kurth A, Zillikens D, Schmidt E. Generalized cowpox infection in a patient with Darier disease. Br J Dermatol. 2011 May. 164(5):1116-8. [Medline].

  26. Blackford S, Roberts DL, Thomas PD. Cowpox infection causing a generalized eruption in a patient with atopic dermatitis. Br J Dermatol. 1993 Nov. 129(5):628-9. [Medline].

Previous
Next
 
A 16-year-old boy with generalized cowpox. Courtesy of Dr. Reinhard Hoepfl, Innsbruck, Austria.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.